Equities

Zhongzhi Pharmaceutical Holdings Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Zhongzhi Pharmaceutical Holdings Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)0.73
  • Today's Change-0.01 / -1.35%
  • Shares traded120.00k
  • 1 Year change-21.51%
  • Beta0.2734
Data delayed at least 15 minutes, as of Feb 16 2026 02:41 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Zhongzhi Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceutical products. The Company's products mainly comprise Chinese patent medicines and decoction pieces, mainly consisting of traditional decoction pieces and modern decoction pieces. The Company operates through two segments, including the Pharmaceutical Manufacturing segment and Operation of the Chain Pharmacies segment. The Company owns brands such as Zhongzhi, Liumian and Caojinghua. The Company mainly conducts its businesses in the domestic market.

  • Revenue in HKD (TTM)2.27bn
  • Net income in HKD23.25m
  • Incorporated2014
  • Employees2.49k
  • Location
    Zhongzhi Pharmaceutical Holdings LtdNo.3 Kangtai Road SouthTorch Development ZoneZHONGSHAN ChinaCHN
  • Phone+86 76 085331222
  • Fax+86 76 085318764
  • Websitehttps://www.zeus.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Wai Yuen Tong Medicine Holdings Ltd721.27m-13.83m399.41m726.00--0.33765.400.5538-0.0123-0.01230.64111.050.41651.419.68950,292.50-0.7998-1.81-1.06-3.1049.8744.67-1.92-11.190.7806--0.2033---4.923.73126.62-56.1631.89--
China NT Pharma Group Co Ltd21.11m-80.24m505.68m21.00------23.96-0.2327-0.23270.0487-0.46460.0546--3.09959,455.00-20.76-10.31----51.27---380.13-97.110.0447-0.39737.95--415.34-24.38-59.32---71.03--
Zhongzhi Pharmaceutical Holdings Ltd2.27bn23.25m630.43m2.49k26.490.51324.380.27770.02760.02762.691.421.052.666.45881,008.101.096.771.6810.4757.1959.641.035.911.0651.800.113438.978.0510.54-41.51-3.6513.6210.79
Uni-Bio Science Group Ltd589.59m91.35m686.69m504.007.551.796.001.160.01520.01520.09760.06411.133.629.181,210,657.0017.516.2122.178.5682.1980.7215.494.963.2259.390.221,633.5814.0821.4316.79102.0432.65--
Fusen Pharmaceutical Co Ltd272.64m-197.95m687.55m1.05k--1.75--2.52-0.2678-0.26780.36880.53030.18751.114.05241,059.40-13.62-2.83-32.04-5.4041.3951.61-72.61-8.000.4241-0.43440.5137---42.36-4.36-420.39---17.55--
Pak Fah Yeow International Ltd199.03m70.97m741.70m100.0010.451.059.563.730.22770.22770.63862.260.22271.8424.741,877,594.007.945.038.685.2487.4482.2335.6623.926.217.720.006894.02-8.649.89-25.1416.8816.37-8.84
Modern Chinese Medicine Group Co Ltd228.75m21.47m813.60m190.0031.581.2323.383.560.03580.03580.38130.91550.3925.897.491,203,966.003.6814.833.9317.5624.5738.449.3817.927.8021.300.00032.85-37.78-0.4333-80.18-26.87112.81--
Lee's Pharmaceutical Holdings Ltd1.44bn97.81m871.48m1.04k8.910.44844.330.60670.16610.16612.443.300.51812.649.171,405,524.002.3213.852.9918.2453.1059.374.4835.220.71117.990.11792.9732.952.81457.55-5.81-10.46-4.28
Data as of Feb 16 2026. Currency figures normalised to Zhongzhi Pharmaceutical Holdings Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

0.01%Per cent of shares held by top holders
HolderShares% Held
Lazard Asset Management LLCas of 31 Jan 202669.00k0.01%
FIL Investments Internationalas of 30 Jun 202553.00k0.01%
Data from 30 Sep 2025 - 30 Sep 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.